Cargando…
Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis
OBJECTIVES: To perform a systematic review of reported HRs of all cause dementia, Alzheimer's disease (AD) and vascular dementia (VaD) for late-life depression and depressive symptomatology on specific screening instruments at specific thresholds. DESIGN: Meta-analysis with meta-regression. SET...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691713/ https://www.ncbi.nlm.nih.gov/pubmed/26692556 http://dx.doi.org/10.1136/bmjopen-2015-008853 |
_version_ | 1782407182122221568 |
---|---|
author | Cherbuin, Nicolas Kim, Sarang Anstey, Kaarin J |
author_facet | Cherbuin, Nicolas Kim, Sarang Anstey, Kaarin J |
author_sort | Cherbuin, Nicolas |
collection | PubMed |
description | OBJECTIVES: To perform a systematic review of reported HRs of all cause dementia, Alzheimer's disease (AD) and vascular dementia (VaD) for late-life depression and depressive symptomatology on specific screening instruments at specific thresholds. DESIGN: Meta-analysis with meta-regression. SETTING AND PARTICIPANTS: PubMed, PsycInfo, and Cochrane databases were searched through 28 February 2014. Articles reporting HRs for incident all-cause dementia, AD and VaD based on published clinical criteria using validated measures of clinical depression or symptomatology from prospective studies of general population of adults were selected by consensus among multiple reviewers. Studies that did not use clinical dementia diagnoses or validated instruments for the assessment of depression were excluded. Data were extracted by two reviewers and reviewed by two other independent reviewers. The most specific analyses possible using continuous symptomatology ratings and categorical measures of clinical depression focusing on single instruments with defined reported cut-offs were conducted. PRIMARY OUTCOME MEASURES: HRs for all-cause dementia, AD, and VaD were computed where possible for continuous depression scores, or for major depression assessed with single or comparable validated instruments. RESULTS: Searches yielded 121 301 articles, of which 36 (0.03%) were eligible. Included studies provided a combined sample size of 66 532 individuals including 6593 cases of dementia, 2797 cases of AD and 585 cases of VaD. The increased risk associated with depression did not significantly differ by type of dementia and ranged from 83% to 104% for diagnostic thresholds consistent with major depression. Risk associated with continuous depression symptomatology measures were consistent with those for clinical thresholds. CONCLUSIONS: Late-life depression is consistently and similarly associated with a twofold increased risk of dementia. The precise risk estimates produced in this study for specific instruments at specified thresholds will assist evidence-based medicine and inform policy on this important population health issue. |
format | Online Article Text |
id | pubmed-4691713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46917132015-12-30 Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis Cherbuin, Nicolas Kim, Sarang Anstey, Kaarin J BMJ Open Neurology OBJECTIVES: To perform a systematic review of reported HRs of all cause dementia, Alzheimer's disease (AD) and vascular dementia (VaD) for late-life depression and depressive symptomatology on specific screening instruments at specific thresholds. DESIGN: Meta-analysis with meta-regression. SETTING AND PARTICIPANTS: PubMed, PsycInfo, and Cochrane databases were searched through 28 February 2014. Articles reporting HRs for incident all-cause dementia, AD and VaD based on published clinical criteria using validated measures of clinical depression or symptomatology from prospective studies of general population of adults were selected by consensus among multiple reviewers. Studies that did not use clinical dementia diagnoses or validated instruments for the assessment of depression were excluded. Data were extracted by two reviewers and reviewed by two other independent reviewers. The most specific analyses possible using continuous symptomatology ratings and categorical measures of clinical depression focusing on single instruments with defined reported cut-offs were conducted. PRIMARY OUTCOME MEASURES: HRs for all-cause dementia, AD, and VaD were computed where possible for continuous depression scores, or for major depression assessed with single or comparable validated instruments. RESULTS: Searches yielded 121 301 articles, of which 36 (0.03%) were eligible. Included studies provided a combined sample size of 66 532 individuals including 6593 cases of dementia, 2797 cases of AD and 585 cases of VaD. The increased risk associated with depression did not significantly differ by type of dementia and ranged from 83% to 104% for diagnostic thresholds consistent with major depression. Risk associated with continuous depression symptomatology measures were consistent with those for clinical thresholds. CONCLUSIONS: Late-life depression is consistently and similarly associated with a twofold increased risk of dementia. The precise risk estimates produced in this study for specific instruments at specified thresholds will assist evidence-based medicine and inform policy on this important population health issue. BMJ Publishing Group 2015-12-21 /pmc/articles/PMC4691713/ /pubmed/26692556 http://dx.doi.org/10.1136/bmjopen-2015-008853 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Neurology Cherbuin, Nicolas Kim, Sarang Anstey, Kaarin J Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis |
title | Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis |
title_full | Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis |
title_fullStr | Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis |
title_full_unstemmed | Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis |
title_short | Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis |
title_sort | dementia risk estimates associated with measures of depression: a systematic review and meta-analysis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691713/ https://www.ncbi.nlm.nih.gov/pubmed/26692556 http://dx.doi.org/10.1136/bmjopen-2015-008853 |
work_keys_str_mv | AT cherbuinnicolas dementiariskestimatesassociatedwithmeasuresofdepressionasystematicreviewandmetaanalysis AT kimsarang dementiariskestimatesassociatedwithmeasuresofdepressionasystematicreviewandmetaanalysis AT ansteykaarinj dementiariskestimatesassociatedwithmeasuresofdepressionasystematicreviewandmetaanalysis |